BAJAJ FINSERV HEALTHCARE FUND - REGULAR - IDCW
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 27-12-2024
AUM:
₹ 320.9 Cr
Expense Ratio
2.37%
Benchmark
BSE Healthcare TRI
ISIN
INF0QA701995
Minimum Investment
500.0
Minimum Topup
100.0
Minimum SIP Amount
500
Fund Manager
Nimesh Chandan,Sorbh Gupta,Siddharth Chaudhary
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| BAJAJ FINSERV HEALTHCARE FUND - REGULAR - IDCW | - | - | - |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
9.631
Last change
0.03 (0.27%)
Fund Size (AUM)
₹ 320.9 Cr
Performance
-4.44% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The Scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
Fund Manager
Nimesh Chandan,Sorbh Gupta,Siddharth Chaudhary
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 8.71 |
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 7.82 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 6.61 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 5.86 |
| Net Receivables / (Payables) | 4.5 |
| Dr. Reddys Laboratories Ltd | 3.52 |
| PIRAMAL PHARMA LIMITED EQ | 3.5 |
| BIOCON LIMITED EQ | 3.43 |
| EMCURE PHARMACEUTICALS LIMITED EQ | 3.4 |
| GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- | 2.81 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 83.5 |
| Fast Moving Consumer Goods | 6.82 |
| N/A | 4.5 |
| Financial Services | 1.79 |
| Capital Goods | 1.56 |
| Consumer Services | 1.34 |
| Chemicals | 0.49 |